Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 767.00K | $ 1.47M | $ 6.19M | $ 591.00K | $ 1.85M |
Total Assets | $ 91.35M | $ 73.05M | $ 42.06M | $ 17.38M | $ 17.10M |
Total Debt | $ 12.96M | $ 12.00M | $ 13.33M | $ ― | $ 1.41M |
Net Debt | $ 12.19M | $ 10.53M | $ 7.14M | $ ― | $ -440.00K |
Total Liabilities | $ 185.81M | $ 104.49M | $ 44.08M | $ 5.81M | $ 5.83M |
Stockholders Equity | $ -94.46M | $ -31.44M | $ -2.02M | $ 11.57M | $ 11.27M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |